DKMS 2024 John Hansen Research Grant accepting applications

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The application period for the DKMS John Hansen Research Grant 2024 began Aug. 1. 

DKMS supports up to four outstanding research projects in the field of stem cell transplantation or cell therapy each year. The grant is aimed at young scientists who have obtained a doctoral degree no more than 10 years ago. 

The grant amounts to €240,000 each and will be paid out over a period of three years. The application deadline is Nov. 30.

DKMS is the world’s largest stem cell donor center, with more than 11.5 million registered potential stem cell donors. The non-profit organization is also deeply involved in the medical and scientific field.

“Every year, more than 1.2 million people around the world are diagnosed with blood cancer and, though a stem cell transplant can save the lives of many of them, not all patients are permanently cured afterwards,” Marcel van den Brink, chairman of the DKMS Medical Council, said in a statement. “Still, relapses and severe complications, most notably graft-versus-host disease, pose major challenges to medicine and science. We want to contribute to the continuous improvement of stem cell transplantation and other cellular therapies.” 

To this end, DKMS runs its own research projects and is committed to ensuring excellent research for the future. 

“It is a matter close to our heart and the DKMS John Hansen Research Grant enables talented young scientists to work on their promising projects for the benefit of patients worldwide,” van den Brink said.

All information on the application modalities, as well as further details on the John Hansen Research Grant, are available on the DKMS Professionals’ Platform. If you have any questions, interested parties are also welcome to contact DKMS by email at grant@dkms.org. 

Table of Contents

YOU MAY BE INTERESTED IN

The FY24 Defense Appropriations Act provides funding for the Glioblastoma Research Program to support research of high potential impact and exceptional scientific merit to reduce the burden of glioblastoma on service members and their families, veterans, and the American public. The managing agent for the anticipated program announcements/funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.
NCI Director Kimryn Rathmell has released her professional judgment budget proposal, requesting nearly $11.5 billion—the same amount as last year’s proposal prepared by her predecessor, Monica Bertagnolli.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login